Home
>
US Stocks
>
Pharvaris NV
Pharvaris NV
PHVS

Pharvaris NV (PHVS)

$14.7526.62%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
15
Today Low/High
14.75 / 15
52 Week Low/High
$13.14 / $42.86
Market Cap
$509.67M

Company Details

Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE.
Organisation
Pharvaris NV
Employees
14

Discover more

Frequently Asked Questions

What is Pharvaris NV (PHVS) share price today?

Can Indians buy Pharvaris NV (PHVS) shares?

How can I buy Pharvaris NV (PHVS) shares from India?

Can Fractional shares of Pharvaris NV (PHVS) be purchased?

What are the documents required to start investing in Pharvaris NV (PHVS) stocks?

We are a SEBI registered investement advisor